Inside the Clinic: Treating AYA ALL - Episode 8
CALBG 10403 in AYA ALL
A panel of experts discusses the use of CALBG 10403 in patients with AYA ALL, highlighting adverse events reported with the regimen and mitigation practices.
Video Player is loading.
Video content above is prompted by the following:
- Discuss the use of CALGB 10403 in AYA ALL. (Stock W et al. Blood 2019)
- Might you have considered a different regimen for this patient?
- Please comment on the key efficacy outcomes.
- What were some AEs reported with this regimen?
- How might you mitigate them?
